Related by context. All words. (Click for frequent words.) 53 parasitological 52 postexposure prophylaxis 52 NJDHSS 51 empiric therapy 51 CPMP 51 RQIA 51 RSV prophylaxis 51 DMEPOS supplier 50 eCTD format 50 MDPH 50 serologic testing 50 Trovax 50 FDAs 49 PFGE 49 anagrelide 49 invasive aspergillosis 49 irinotecan oxaliplatin 49 postmarket surveillance 49 BEXXAR Therapeutic Regimen 49 indications contraindications 49 stool specimen 49 tropism testing 49 hepatic insufficiency 49 hepatitis C hepatitis B 48 LibiGel NDA 48 spokeswoman Donna Leusner 48 Advaxis Incorporated OTCBB ADXS 48 ANPRM 48 VP# [004] 48 OHRP 48 orf virus 48 influenza antiviral medications 48 FFDCA 48 NJDEP 48 toxicological studies 48 bloodborne 48 OPMC 48 postexposure 48 Approvable 48 riociguat 48 OvaRex MAb 48 MPNs 48 renoprotective 48 treatment naive genotype 48 MVLWB 47 daptomycin 47 immunization registries 47 immune reconstitution syndrome 47 APEX AMI 47 JAAPA 47 chest radiographs 47 BETAS 47 BOAH 47 dose escalation phase 46 OEHHA 46 prevent reoccurrences 46 Combating Counterfeit Drugs 46 selenium supplementation 46 PIX# [002] 46 adeno associated viruses 46 Recombinant interferon alpha 46 Confirmatory tests 46 TORISEL TM 46 antimicrobial prophylaxis 46 Alequel 46 NHPs 46 Complete Response 46 serologic 46 MAGE A3 ASCI 46 pharmacogenetic testing 46 prudent layperson 46 DOHMH 46 USDA APHIS 46 SIMPONI TM 46 www.mass.gov dph 46 vaccine RotaTeq 46 PGx 46 C. difficile toxins 46 multidose vials 46 FDA Adverse Event 46 Expedited Review 46 fi ndings 46 PREVU x LT 46 Methicillin Resistant Staph Aureus 46 phototoxicity 46 Octreolin 46 WHO Prequalification 45 bacillus anthracis 45 FDA Investigational Device 45 hypersensitivity allergic reactions 45 LEAPS H#N# 45 polycythemia vera PV 45 NHSN 45 pertussis Tdap vaccine 45 UPLYSO 45 genotypic resistance 45 epidural steroid injection 45 Smallpox vaccination 45 ACGIH 45 cGMPs 45 anthracycline containing 45 Confirmatory testing 45 transfusion transmitted 45 www.nyhealth.gov 45 Anidulafungin 45 Serious Adverse Events 45 ECVAM 45 Mantoux test 45 Premarket Approval 45 tipranavir ritonavir 45 trastuzumab Herceptin ® 45 DOBI 45 OSDH 45 Notified Bodies 45 NSQIP 45 syndromic 45 periodically reassessed 45 PrevOnco 45 enterococcal 45 genomic biomarker 45 IGRAs 45 MGCD# clinical trials 45 ADVEXIN therapy 45 ACNFP 45 ADPH 45 Swine Flu H#N# 45 eribulin mesylate 45 replicon 45 erythropoietic 45 NTCD 45 eosinophilic pneumonia 45 malaria endemic regions 45 notifiable diseases 45 recombinant interferon 45 EPA Safe Drinking 45 diacetyl exposure 45 Claire Pospisil 45 Subpart E 45 HIV HCV coinfected 45 communicable illness 45 SGEIS 45 malignant ascites 45 Chlamydia gonorrhea 45 CDPHE 44 Act SEQRA 44 intestinal biopsy 44 Prequalification 44 laparoscopic radical nephrectomy 44 ISTODAX 44 HBV infections 44 gonococcal infections 44 reregistration 44 MSDH 44 nosocomial pneumonia 44 OMIG 44 clinico pathological 44 Bacteremia 44 SCENIHR 44 Catheter Associated 44 Registry NOPR 44 pill Contrave 44 histologically proven 44 DHMH 44 REMINYL ® 44 #-#-PA-HEALTH 44 antiangiogenic agent 44 Hythiam PROMETA 44 www.hhs.gov ocr 44 guideline concordant 44 CFR § #.# [007] 44 DDMAC 44 beryllium sensitization 44 mutated K ras 44 prospective multicenter study 44 casopitant 44 serologic tests 44 Enzastaurin 44 Accelerated Approval 44 NMDA antagonists 44 CDPH 44 G6PD deficiency 44 Afatinib 44 BSIs 44 tumorigenicity 44 NOPR 44 transrectal ultrasound guided 44 NPM1 mutation 44 spokeswoman Roseanne Pawelec 44 Hib vaccination 44 NPDES permits 44 Pneumocystis carinii pneumonia 44 HPV genotyping 44 VTE prevention 44 NeuroStar TMS Therapy 44 refractory CLL 44 Shigamabs 44 EPCRA 44 rhLF 44 Disease Registry ATSDR 44 TransVax ™ 44 antibiotic prophylaxis 44 HPV Human Papillomavirus 44 tularemia infections 44 oncological outcomes 44 requiring Asthmatx 44 Enterococci 44 chickenpox varicella 44 ISDH 44 www.ct.gov dph 44 Pafuramidine 44 APEX AMI trial 44 BLA filing 43 Percutaneous Coronary Interventions 43 null responder HCV 43 BRILINTA 43 www.ClinicalTrials.gov 43 cranial irradiation 43 enzyme immunoassay EIA 43 papillary renal cell carcinoma 43 k Premarket Notification 43 prucalopride 43 reapproval 43 ADACEL vaccine 43 anthrax ricin 43 Zanamivir 43 beachwater 43 Tenderers 43 Diabetic Foot Ulcer 43 coli bacteria 43 syndromic surveillance 43 Clinical Trials Directive 43 AFRS TM 43 UKIPO 43 ATSDR 43 nonclinical studies 43 helminth 43 xxxi adverse tax 43 F.D.A. 43 HCV SPRINT 43 Begin Clinical Trials 43 OraQuick test 43 CIP TRAMADOL ER 43 Removab 43 Shigella bacteria 43 CIMZIA TM certolizumab pegol 43 Flavivirus 43 Targretin capsules 43 WNV infections 43 C. diff infection 43 Requesters 43 gastric adenocarcinoma 43 Simulect 43 IDPH 43 inspectional observations 43 Anaplasmosis 43 causative pathogen 43 eMDR 43 bloodborne diseases 43 Cloretazine 43 immunosuppression therapy 43 OCABR 43 antineoplastic 43 tetanus immunization 43 WCHD 43 Hedgehog Pathway Inhibitor 43 spokeswoman Betsy Lordan 43 Federal eRulemaking Portal http:/www.regulations.Tavarekere 43 BrachySil TM 43 PDEIS 43 lymph node biopsy 43 coagulation assays 43 supplemental biologics 43 Novel H#N# Influenza 43 acyclovir Lauriad ® 43 LDTs 43 Lipsovir ® 43 NIH grantees 43 orBec 43 www.weitzlux.com 43 edifoligide E2F Decoy 43 prescribing beta blockers 43 anti androgens 43 Remedial Investigation 43 Escherichia coli Klebsiella pneumoniae 43 fusion enhancers 43 clinicopathologic 43 hypereosinophilic syndrome 43 non nucleoside 43 heparin induced thrombocytopenia 43 Requester 43 alemtuzumab MS 43 carcinogenicity studies 43 Acute Decompensated Heart Failure 43 relapsed MM 43 menadione 43 HCV RESPOND 2 43 Genetic Therapies Directorate 43 HBsAg 43 Fondaparinux 43 Approvable letter 43 conduct postmarketing 43 spokesman Don Ralbovsky 43 Efficacy endpoints 43 www.health.state.mn.us 43 spontaneous regression 43 pharmacoeconomic analysis 43 distributing misbranded 43 Histological 43 Premarket Notification 43 acyclovir Lauriad R 43 Subtitle D 43 EPA 43 Transmissible 43 CYP #D# 42 SCDHEC 42 percutaneous drainage 42 TLVs 42 virucidal 42 AIDAC 42 Informed consent 42 pemoline 42 ENRICH trial 42 Subpart H 42 USEPA 42 pelvic ultrasound 42 USDA FSIS 42 dosage regimens 42 SIMPONI ® 42 RAMQ 42 Amodiaquine 42 histological subtype 42 antemortem 42 Smallpox Vaccination Program 42 DATES Comments 42 equine WNV 42 OVIDE 42 sorafenib Nexavar 42 Jalil Isa 42 National Coverage Determination 42 metastatic neuroendocrine tumors 42 NJSA #:#-#.# [003] 42 Pseudomonas aeruginosa infections 42 STEPHEN MORRISON 42 ALK inhibitors 42 pulls Darvon painkiller 42 SWHCS 42 Idenix Novartis 42 Communications DDMAC 42 Vidaza azacitidine 42 toxigenic Clostridium difficile 42 azinphos methyl 42 HBeAg + 42 spokeswoman Jessica Frickey 42 Onconase 42 parenteral antibiotics 42 spokeswoman Liz Sharlot 42 Anaplasma 42 preapproval inspection 42 EIR EIS 42 ß blockers 42 prognostic biomarker 42 Marketing Authorisation Application MAA 42 imatinib resistance 42 Supplemental Generic 42 Hepatitis B Virus 42 hoFH 42 visit www.ashrae.org 42 immunomodulatory therapies 42 Tasigna nilotinib 42 causal inferences 42 oral JAK1 42 histone deacetylase inhibitor 42 tigecycline 42 PMPRB 42 MEDMARX 42 Marketing Authorisation Holders 42 dioxin reassessment 42 Marketing Authorization Applications 42 nosocomial pneumonia NP 42 Environmental Conservation NYSDEC 42 Daptomycin 42 severe hypercholesterolemia 42 curative therapy 42 multiorgan 42 TASKi3 42 pneumococcal vaccinations 42 pertussis vaccinations 42 spokesman Fernando Senra 42 etiologic 42 CEAA 42 Lofexidine 42 Peer Reviewed Medical 42 alachlor 42 S aureus 42 traceback investigations 42 chemosensitivity 42 Environmental Protection NJDEP 42 Flu.gov 42 DNRs 42 Progressive Multifocal Leukoencephalopathy 42 ANDA applicant 42 FDA Approvable Letter 42 MRMIB 42 ELISPOT 42 histopathological examination 42 rheumatic disorders 42 antiplatelet medications 42 BPH LUTS 42 NYSDEC 42 HealthyToys.org 42 ConclusionThis 42 RWQCB 42 FIPPA 42 Remedial Action Plan 42 fosbretabulin 42 prospective nonrandomized 42 Glybera R 42 Adverse Event Reporting 42 Pneumococcal vaccine 42 AGHD 42 PIX# trial 42 G CSFs 42 Corrective Action Plan 42 immunosuppressive therapies 42 DTSC 42 randomized multicenter trial 42 refractory chronic lymphocytic 42 latent tuberculosis infection 42 WIRB 42 HCV Genotype 42 HepDirect prodrug 42 ribavirin therapy 42 non nucleoside HCV 42 pretransplant 42 recurrent glioblastoma multiforme 42 Hazardous Waste Regulations 42 ORWH 42 Act CEAA 42 haematologic 42 pafuramidine 42 intra abdominal infections 41 ultrasonographic examination 41 N. gonorrhoeae 41 Mycobacterium tuberculosis MTB 41 microbiological contaminants 41 NCDENR 41 SPRYCEL ® 41 thalidomide Thalomid 41 trichomonas 41 Dalbavancin 41 generation purine nucleoside 41 proposed rulemaking NPRM 41 mediastinitis 41 telomerase activators 41 hydrogeological studies 41 Sapse 41 MRHA 41 antiepileptics 41 FDA 41 Pre IND 41 Current Controlled Trials 41 Health IDPH 41 busulfan 41 Carotid Revascularization Endarterectomy vs. 41 colorectal screenings 41 Submittals 41 Pyridorin 41 Severe Primary IGFD 41 relation thereto 41 Environmental Quality Review SEQR 41 CFR § #.# [001] 41 SEQR 41 rFVIIa 41 neoadjuvant setting 41 Pre Exposure Prophylaxis 41 potent cytotoxic 41 ACZ# 41 cancer causer 41 EPA Brownfields Program 41 By Suria Rina 41 Phospha E R 41 MDRs 41 tentative nonconfirmation 41 babesia 41 Methyl Iodide 41 cytomegalovirus infection 41 Monoclonal antibody 41 Estrogen Receptor 41 prescribe medicines 41 Determination Letter 41 COSHH 41 ICMJE 41 APVMA 41 novel emulsion formulation 41 zinc nasal gel 41 publichealth 41 treat chronic sinusitis 41 draft SEIS 41 USA# strain 41 WNv 41 blood borne pathogen 41 sNDAs 41 chronic idiopathic thrombocytopenic purpura 41 Leni Fortson 41 lymphomas leukemias 41 Act AHERA 41 MAVDT 41 SWRCB 41 chronic GVHD 41 WAC #-#-# 41 EGFR TKIs 41 Aviptadil 41 spokeswoman Tisha Petteway 41 Liver transplantation 41 quinolone antibiotics 41 Sexually transmitted 41 SDWA 41 gene rearrangements 41 C.difficile infections 41 Pemetrexed 41 ADAAG 41 spokesman Phil Budahn 41 Marla Augustine 41 Substances Hazardous 41 Beauveria bassiana 41 lung biopsy 41 TLR antagonist 41 spokeswoman Carole Saindon 41 lamivudine resistant 41 β blockers 41 NSPIRES 41 biologic DMARD 41 spokeswoman Claire Pospisil 41 DHCS 41 ECG Warehouse 41 chicken pox vaccination 41 vapor intrusion 41 Health MDPH 41 achieved CCyR 41 Competitive Impact Statement 41 Bfad 41 adverse cytogenetics 41 MGd 41 journal Epilepsia 41 MDCH 41 Histopathologic examination 41 GRAS notification 41 tumor histology 41 simian foamy virus 41 adjuvant therapies 41 seroquel quetiapine 41 NPM1 41 epoetin alpha 41 Zoonotic Disease 41 authority Gurian Sherman 41 Diabetic Neuropathy 41 ZOSTAVAX 41 sunitinib Sutent 41 Biologic License Application BLA 41 metastatic malignant 41 FMIA 41 Toxic Substance 41 www.grants.gov 41 Edurant 41 Triage Stroke Panel 41 www.ferc.gov 41 DXA scan 41 polyarticular 41 www.osha.gov 41 biologic DMARDs 41 LCHD 41 Toxic Substances Control DTSC 41 Nephrogenic Systemic Fibrosis 41 APHIS 41 chronic beryllium 41 thromboembolic disease 41 USDOL 41 Certified Renovator 41 supplemental EIS 41 NPDB 41 QT Prolongation 41 genomewide association study 41 PCIP 41 BPS IC 41 NHDES 41 pancreatic enzyme replacement 41 hepatitis B vaccinations 41 C. diff infections 41 disinfectant byproducts 41 DHSS 41 cervicitis 41 sublingual fentanyl 41 pain palliation 41 intravenous tissue plasminogen 41 severe gastroparesis 41 swineflu 41 undergoing colonoscopy 41 MMSEA 41 Premarket Approval Application 41 Deficiency Notice 41 monoclonal anti 41 FDEP 41 assigned PDUFA 41 anthrax tularemia 41 spokeswoman Phillippa Cannon 41 gonococcal 41 cefprozil 41 CMV reactivation 40 Iron Deficiency Anemia 40 DOH 40 FDA Accelerated Approval 40 Accelerated Partial Breast Irradiation 40 NIH NIAID 40 www.health.state.pa.us 40 H1NI vaccine 40 Warfarin Coumadin 40 haematological 40 gastrointestinal stromal tumors GISTs 40 renal cysts 40 Cosmetic Ingredient Review 40 bronchogenic carcinoma 40 pulmonary resection 40 urothelial carcinoma 40 genotoxicity reproductive toxicology 40 non compliances 40 Board DSMB 40 naturally occurring bacterium 40 florbetaben 40 colorectal adenocarcinoma 40 Hematologic 40 Recurrent Glioblastoma 40 Zavesca R 40 Veterinary Medicines Directorate 40 spokeswoman Martha Framsted 40 VerifyNow P#Y# 40 periprosthetic joint 40 WDEQ 40 cardiac repolarization 40 SaferProducts.gov 40 postmarket safety 40 MHLW 40 NASDAQ Listings Qualifications 40 draft Supplemental Generic 40 medico legal examination 40 trimester ultrasound 40 PELs 40 acadesine 40 MEDCAC 40 Marion VAMC 40 Rule #:#-# [002] 40 somatic mutation 40 Pandemic Flu Vaccine 40 GnRH agonists 40 Third Amended Complaint 40 DCHD 40 CIMYM 40 bronchoalveolar lavage BAL 40 sacral neuromodulation 40 NRTL 40 Eddy Bresnitz 40 Welfare DPW 40 ToxCast ™ 40 nasal endoscopy 40 efalizumab 40 embryo biopsy 40 Passive euthanasia 40 u nless 40 analy sis 40 Complete Response CR 40 prescribe Suboxone 40 Occupational Disease 40 nevirapine regimen 40 K. pneumoniae 40 Golimumab 40 VAMCs 40 relicensure 40 Metarhizium anisopliae 40 Idiopathic Pulmonary Fibrosis 40 ozone attainment 40 NYSED 40 hepatorenal syndrome 40 Injunctive relief 40 Boiler MACT 40 boards IRBs 40 humoral responses 40 Raptiva ® 40 Katkowsky 40 Susceptibility Testing 40 visit www.health.state.pa.us 40 Equine Infectious Anemia 40 CURES 40 Draft SEIS 40 NEO3 40 DEET picaridin 40 Rottenstein Law Group 40 Postmarket 40 NCCPA 40 histamine dihydrochloride 40 CRMD 40 Radio Frequency Ablation 40 PM#.# NAAQS 40 Zoonotic 40 Environmental Impact Assessments 40 chickenpox vaccinations 40 OFCCP jurisdiction 40 upper gastrointestinal endoscopy 40 ano genital warts 40 www.aahealth.org 40 Surgical resection 40 Tumor Response 40 adjudicatory proceeding 40 Centralised Procedure 40 oral alitretinoin 40 Marketing Authorisation Application 40 allogeneic hematopoietic cell 40 postmarketing surveillance 40 Environ mental Protection Agency 40 Vapor Intrusion 40 selective modulator 40 valent pneumococcal 40 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 40 decompressive surgery 40 CFR § #.# [006] 40 HBeAg negative 40 Combidex 40 DDRB 40 retrospective cohort study 40 romidepsin 40 Thorough cooking kills 40 isoniazid preventive therapy 40 allogeneic HSCT 40 Slip op 40 reexamination proceeding 40 LDEQ 40 MDDS 40 Cignet 40 spokeswoman Stacy Kriedeman 40 Deficiency Letter 40 Nonpoint Source 40 tickborne 40 Listing Qualifications Panel 40 Oral Polio Vaccine 40 DMHC 40 Total Coliform Rule 40 brucella 40 Appellate Panel 40 kidney urologic 40 lymphoid malignancies 40 enhanced ADCC 40 chemoprevention trials 40 NUREG 40 HIPAA Privacy Rule 40 DaTscan 40 endometrial biopsies 40 SNS# T 40 MDEQ 40 anal swabs 40 malignant pleural mesothelioma 40 END FOOTNOTE 40 palpably unreasonable 40 CRp 40 Antiviral Drug 40 www.cdc.gov swineflu 40 § #.# [002] 40 chemical C8 40 premarket notification 40 CPT coding 40 Agency CEAA 40 Fampridine SR NDA 40 OIG 40 isoflavone supplement 40 Erythropoiesis stimulating agents 40 PRECISE Trial 40 EndoBiologics 40 monoinfected patients 40 RREs 40 Citizen Petition 40 RIDEM 40 trihalomethanes THMs 40 Varicella Zoster 40 Federal Creosote 40 Petitioner contends 40 NASPER 40 levaquin levofloxacin 40 PADEP 40 transmittable diseases 40 jurisdictional defect 40 serological testing 40 c myb 40 variant allele 40 spokeswoman Jamie Hais 39 hepatic failure 39 PDUFA reauthorization 39 Compassionate Use 39 NDPSC 39 dysentery typhoid 39 dioxin PCBs 39 measles mumps rubella varicella 39 unblind 39 bioequivalent versions 39 VAOIG 39 listeria salmonella 39 EEOICPA 39 NMED 39 DATES Written comments 39 bloodborne pathogen 39 carcinoid tumors 39 Establishment Inspection 39 r hGH 39 hep B 39 CHRE 39 HIB vaccine 39 Environment CDPHE 39 groundwater contaminant 39 allowability 39 CINTREDEKIN BESUDOTOX 39 dimeglumine 39 Med eXpert 39 Triapine 39 Epivir HBV 39 ara C 39 cerebral vasospasm 39 Common Procedure Coding 39 Paragraph IV Notice 39 urine cytology 39 preclinical efficacy 39 endoscopic examinations 39 ISRCTN# 39 nonalcoholic steatohepatitis NASH 39 hematopoietic cancers 39 FDA Modernization Act 39 BCG refractory 39 MICHAEL REYNOLDS 39 acetonide FA 39 pixantrone NDA 39 ARCOXIA 39 polybrominated diphenyl ether 39 poor metabolizers 39 highly pathogenic influenza 39 OROS R Hydromorphone 39 pelvic lymphadenectomy 39 Onconova Therapeutics Inc. 39 biliary tract cancer 39 confirmatory testing 39 intravenous dosing 39 Tesmilifene 39 Exelbine NDA 39 NWHC 39 anaphylactic reactions bronchospasm 39 Environmental Remediation 39 COMARE 39 DDP# 39 K ras mutations 39 NOMID 39 SNHD 39 spokeswoman Amanda Eamich 39 ritonavir boosted protease inhibitor 39 undetectable HBV DNA 39 GCP compliant 39 mycosis fungoides 39 spokeswoman Clair Boatwright 39 Healthcare Acquired Infections 39 TNF antagonist 39 Inhaled AAT 39 Biologics Licensing 39 diagnostic laparoscopy 39 Contraindications 39 www.idph.state.il.us 39 CRKP 39 differin adapalene 39 biliary stones 39 HCV polymerase 39 depositions interrogatories 39 PROCLEIX TIGRIS System 39 Candida infection 39 Civacir 39 SEQRA 39 EMPOWER TM 39 immunocompetent 39 Presentence 39 preoperative MRI 39 ODEQ 39 thyroid carcinoma 39 microbiological testing 39 GERD migraine headaches 39 Substances Control 39 shockwave lithotripsy 39 TCHD 39 u pon 39 regulations.gov 39 rbGH 39 airborne pollutant 39 Coronary angiography 39 Zenvia Phase III 39 amalgam fillings mercury vapor 39 NPDES permitting 39 eSubmissions 39 cystic fibrosis bronchiectasis 39 Chronic HCV 39 propoxur 39 MfE 39 gastrointestinal stromal tumors GIST 39 Accelerating apoptosis may 39 La.Civ.Code art 39 pleural fluid 39 DiNapoli auditors 39 Gorlin syndrome 39 audiometric testing 39 prequalification questionnaire 39 MYCAMINE 39 prescribe Seroquel 39 cystic fibrosis bronchiectasis inhalation 39 Draft EIR 39 heptachlor 39 enoxaparin Lovenox 39 primary hyperparathyroidism 39 pharmacodynamic parameters 39 DECCW 39 Barr ANDA 39 AHQA 39 Sanitarians 39 asbestos abatement contractor 39 BioMarck 39 USDOJ 39 miRview squamous 39 Act SDWA 39 metastatic malignant melanoma 39 orthopoxvirus 39 NDA BLA 39 Tainted peanut butter 39 gamete donation 39 myopathy rhabdomyolysis 39 lampricide 39 PFOAs 39 histopathological 39 spokeswoman Skylar McElhaney 39 CSR #-#.# 39 KRAS gene mutations 39 ALT flares 39 Master File DMF 39 Silenor NDA 39 MGUS 39 Contaminated Sites 39 qui tam actions 39 CERHR 39 capsular polysaccharide 39 diquat 39 BCL#A 39 RFEs 39 Protease Inhibitor 39 Amended Notice 39 visit http:/www.depweb.state.pa.us keyword 39 myelodysplastic myeloproliferative diseases 39 dental amalgams 39 Meningococcal Meningitis 39 infection preventionists 39 Dangerousness 39 Lepto 39 pleiotropic 39 Environmental Quality MDEQ 39 MAA submission 39 TSPC 39 NCCN Drugs & 39 psoriatic arthritis PsA 39 codal 39 SVEP 39 judicially reviewable 39 PQQ 39 NPDES 39 PHEMCE 39 nasal carriage 39 RIDDOR 39 gene loci 39 Sole Source 39 supplemental Biologics License Application 39 NexMed Receives 39 TLR antagonists 39 contemporaneous documentation 39 Habit OPCO 39 www.doh.wa.gov 39 Toxics Rule 39 Corgentin 39 Hepatitis B vaccinations 39 KEGG 39 hematological parameters 39 Enesta Jones 39 industrial hygienist 39 metastatic GIST 39 Vascugel ® 39 Health MDCH 39 non selective NSAIDs 39 larvacides 39 Dig Safe 39 Draft EIS 39 VDH 39 tonsillar hypertrophy 39 Administration MIOSHA 39 von Willebrand 39 Federal eRulemaking portal